Ubrogepant
Back to searchScientific Name: | Ubrogepant |
Brand Name: | Ubrelvy |
Company Owner: | Not Available |
Mechanism Of Action | The currently accepted theory of migraine pathophysiology considers dysfunction of the central nervous system, in particular the trigeminal ganglion, to be the root cause behind the condition. |
Description of the Drug: | Ubrogepant is an oral CGRP antagonist used in the acute treatment of migraine with or without aura. |
Protein Data Bank: | Not Available |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB15328